Categories: News

Crescent Innovations reports strong interest in asset sale

WESTFORD, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) — Crescent Innovations Inc. reports that activity surrounding sale of its joint, bone and skin repair technology remains strong even at this late date. Crescent Innovations had previously announced the sealed bid deadline for sale of its assets had been moved to September 13, 2024 due to high interest.

Al Prescott noted that, “Not only has the activity in tissue regeneration been brisk, but the veterinary, agricultural and waste water treatment interest has increased.”

Poly-gamma-glutamic acid, and the other associated technologies, are novel biological polymers with unique and relevant properties to large and diverse market areas. They include;

  • Medical device – osteoarthritis, joint repair and bone repair
  • Wound care – diabetic ulcer, burns and skin repair
  • Beauty – injectable beauty compounds similar to botox
  • Seeding and fertilizing
  • And Waste water recovery
  • Drinking water purification

Chris Finn, is president of the advisory firm Alternotio which Crescent Innovations has retained Alternotio to sell these assets using a sealed bid sales process. The assets will be sold at a sealed bid sale on September 13, 2024, at noon. Parties interested in purchasing any or all of the assets must sign a confidentiality agreement, which can be obtained by contacting Chris Finn at info@alternotio.com or calling +1 (978) 882-2586. Negotiated offers are welcome, but any negotiated sale must be concluded prior to opening bids on the date specified above and must conform to the terms set forth for sealed bids.

About Crescent Innovations Inc.

Crescent Innovations Inc. is a firm focused on the development of biological polymers to create non surgical regenerative solutions for chronic conditions. The firm currently is focused on innovating technology to solve TMJ disorders and singular maladies. If interested in TMJ disorders, please contact Crescent Innovations directly at www.crescentinnovations.com

About Alternotio.

Alternotio is an advisory firm, that specializes in the sale of non-lead and distressed intellectual property. Alternotio occasionally works with unique tangible assets that have a substantial intellectual property component.

Contacts:

Al Prescott, alprescott@crescentinnovations

Chris Finn, info@alternotio.com 

Staff

Recent Posts

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

2 hours ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

2 hours ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

2 hours ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

2 hours ago

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…

2 hours ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…

2 hours ago